Displaying items by tag: department of anesthesiology and perioperative medicine

Multifidus stimulation is for patients with chronic, non-surgical low back pain who demonstrate impaired function in the muscles that stabilize the spine.
This new grant will be used to develop a full-scale family of devices for inhaled nitric oxide delivery for patients with pulmonary hypertension that can be used in health care facilities and for at-home care.
The new treatment involves using a spinal cord stimulator that sends electrical impulses into the spinal cord. The device responds to the spinal cord in real time and can adjust the electrical output 50-100 times per second based on what is happening in the spinal cord.
The temporary PNS device can be used to treat chronic nerve pain, as well as joint pain and back pain, for patients for whom oral medications are not effective, or who wish to minimize the use of medications or more invasive procedures.

Chronic pain often leads to depression, which increases suffering and is clinically difficult to treat. Understanding the underlying mechanism identifies a potential therapeutic target for treatment.
Record $95 million Heersink lead gift to advance strategic growth and biomedical innovation.
Tagged under
A drug that inhibits the protease plasmin is hypothesized to reduce the infectivity and virulence of the virus, as measured by reduced need for hospitalization within a week.
UAB and Polish researchers propose that the COVID-19 virus acts as a microRNA “sponge” to deplete miRNA levels in ways that aid viral replication and stymie the host immune response.
A study identifying biomarkers for certain neuroendocrine cancers demonstrates a novel approach for identifying and detecting tumor drivers, giving this diagnostic-therapeutic coupled system a broad translational potential.
Page 1 of 4